Cassaday & Co Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Cassaday & Co Wealth Management's IONS Position: Q3 2026 in Review
Cassaday & Co Wealth Management held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 400 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #848.
Cassaday & Co Wealth Management first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.7K in Q2 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Cassaday & Co Wealth Management held 400 shares of Ionis Pharmaceuticals worth $17.9K as of Q3 2026.
- Cassaday & Co Wealth Management left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
- Ionis Pharmaceuticals made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #848 holding.
- Cassaday & Co Wealth Management first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Cassaday & Co Wealth Management's Ionis Pharmaceuticals position peaked at $31.7K in Q2 2026.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.